News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Study Backs Roche Holding AG’s (JOBS) New Use of Avastin Cancer Drug
August 18, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Swiss-based Roche Holding AG said on Tuesday a study had showed its drug Avastin increased life expectancy for women with breast cancer without the disease getting worse, when used alongside common chemotherapies.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
Europe
MORE ON THIS TOPIC
Vaccines
Quick on Its Feet: Novavax Adapts to Continued Regulatory Uncertainty
June 20, 2025
·
3 min read
·
Heather McKenzie
Obesity
Scholar Rock Jumps on Weight Loss Data for Zepbound/Repurposed Antibody Combo
June 18, 2025
·
2 min read
·
Dan Samorodnitsky
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
·
2 min read
·
Tristan Manalac
Approvals
CSL Wins First Approval for Preventive Hereditary Angioedema Drug
June 18, 2025
·
2 min read
·
Tristan Manalac